Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The company faces significant challenges, including a notable revenue decline and cash flow issues. Despite some positive developments like new partnerships and customer acquisitions, the guidance indicates a substantial revenue drop in Q1 2025. Additionally, the lack of a share buyback program and high disenrollment rates further contribute to a negative outlook. The absence of analyst sentiment from the Q&A section does not offset these concerns.
Revenue $3.1 million, reflecting an 11% decrease year-over-year due to the loss of a customer earlier this year, slightly offset by new customers signed during 2024.
Revenue per health plan enrolled member per month Approximately $500, representing a sequential increase from $449 in Q3 2024 but a decrease from $546 in Q4 2023. The sequential increase is attributed to disenrolled members related to a customer termination, which reduced the average members enrolled at the end of the quarter.
Membership Enrollment 2,125 members at the end of Q4, with a net increase of 60 members during the quarter. This includes 1,641 new members enrolled during the quarter, which is the highest total enrollment in a quarter since Q3 2021.
Gross Margin 61%, a slight decrease from 62% in Q3 2024 and 64.6% in Q4 2023. Anticipated to decrease slightly into the mid-50s based on current pricing and revenue mix.
Operating Cash Flow Negative $4.3 million, compared to negative $3.6 million in the same quarter last year and negative $1.4 million in Q3 2024.
Cash Reserve $5.7 million at year-end, a decrease from $9.7 million at the conclusion of the previous year.
Disenrollment Rate 19%, compared to 11% in Q3 2024 and 16% in Q4 2023. The higher disenrollment rate is due to the disenrollment of members from the customer termination previously discussed.
Graduation Rate from WholeHealth+ program Approximately 11% of the members enrolled at the beginning of the quarter, consistent with previous periods.
WholeHealth+ Solution Launch: Launched WholeHealth+ solution with Intermountain Health, enrolling over 325 members in the first month.
Engage Program Enrollment: Enrolled over 450 members in the Engage Program from a Northeast regional plan since launch.
New Customer Acquisitions: Secured three new regional health plan customers and four health plan expansions in the last 14 months.
Medicare Advantage Partnership: New partnership with Intermountain Health for Medicare Advantage population in Nevada.
Geographic Expansion: Existing customer expanded its service area to five Florida regions in February 2025.
Revenue per Member: Average revenue per health plan enrolled member per month increased to approximately $500.
Enrollment Rate: Achieved a 50% enrollment rate in Q4, highest since Q3 2021.
Graduation Rate: 226 members graduated from the WholeHealth+ program, consistent with previous periods.
Value-Based Provider Designation: Engaging with payer partners as a value-based provider, enhancing economic model and access to reimbursable fees.
Sales Pipeline Growth: Active discussions with six additional health plan prospects, with potential to double revenue.
Revenue Decline: Q4 revenue reached $3.1 million, an 11% decrease compared to the same period last year, primarily due to the loss of a customer.
Disenrollment Rate: The average monthly disenrollment rate increased to 19%, compared to 11% in Q3 2024, attributed to customer termination.
Cash Flow: Operating cash flow for Q4 showed a negative $4.3 million, indicating financial strain.
Gross Margin: Gross margin decreased to 61%, with expectations of further decline into the mid-50s due to pricing and revenue mix.
Customer Acquisition Risks: New customers have different pricing structures, which may affect revenue stability and predictability.
Regulatory Approval: Ontrak applied for state Medicaid approval to serve a new Medicaid plan, which is a critical step for partnership execution.
Economic Factors: Anticipated revenue for Q1 2025 is projected to be between $2 million and $2.3 million, reflecting a 27% to 36% sequential decrease.
New Customers: Secured three new regional health plan customers and four health plan expansions in the last 14 months.
WholeHealth+ Solution Launch: Launched WholeHealth+ with Intermountain Health, enrolling over 325 members in the first month.
Contract Extensions: Secured a three-year contract extension with Sentara Health plans, expanding outreach by 6 times.
Value-Based Provider Designation: Engaging with payer partners as a value-based provider, enhancing economic model and access to reimbursable fees.
Sales Pipeline Growth: Active discussions with six additional health plan prospects, including a large Midwestern plan that could double revenue.
Q1 2025 Revenue Guidance: Anticipate revenue between $2 million and $2.3 million, a 27% to 36% sequential decrease.
2025 Revenue Outlook: Expect to double revenue in 2025 and again in 2026.
Gross Margin Projection: Anticipate gross margins to decrease slightly into the mid-50s.
Annualized Revenue Opportunities: Bottom of the funnel could add $14 million to $16 million, while middle opportunities represent $20 million to $28 million.
Share Buyback Program: None
Despite enrollment growth and strategic initiatives, the company faces significant challenges: a 25% YoY revenue decrease, reduced gross margins, and ongoing cash flow issues. The positive aspects, such as NCQA certification and potential revenue growth, are overshadowed by reliance on new contracts and financial strain. The lack of significant Q&A insights further supports a negative outlook. Overall, the negatives outweigh the positives, suggesting a potential stock price decline of 2% to 8%.
Despite strong operational updates and strategic initiatives, the significant EPS miss and anticipated revenue decline raise concerns. While new partnerships and expansions are promising, the lack of immediate financial impact and unclear management responses add uncertainty. The absence of a share buyback program and potential regulatory and competitive risks further dampen sentiment. Given these factors, the stock price is likely to experience a negative movement.
The company faces significant challenges, including a notable revenue decline and cash flow issues. Despite some positive developments like new partnerships and customer acquisitions, the guidance indicates a substantial revenue drop in Q1 2025. Additionally, the lack of a share buyback program and high disenrollment rates further contribute to a negative outlook. The absence of analyst sentiment from the Q&A section does not offset these concerns.
Despite strategic initiatives and potential growth opportunities, the earnings call reveals significant challenges: a 31% revenue decrease YoY, declining gross margins, and liquidity concerns with reduced cash reserves. These outweigh the positive aspects like new customer acquisitions and revenue projections. The lack of a shareholder return plan further dampens sentiment. The Q&A section did not provide substantial positive insights to alter this outlook. Overall, the financial health and market strategy weaknesses suggest a negative stock price movement in the near term.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.